The Drug Technical Advisory Board (DTAB) has advised the Government to revoke the suspension of the diabetes drug pioglitazone.
The DTAB met on July 19 and recommended that pioglitazone be put back in the market in
box warning about bladder cancer. India
The DTAB is an advisory body and the government may or may not accept its advice but it is likely that the recommendations may be accepted.